Download the brochure Health & Wellbeing
Get it
C5KH

Health & Wellbeing

UCITS ETF
Holdings 75
Expense ratio 0.49%
Ticker C5KH
ISIN IE0001EY64U4

Fund Vision

The CIRCA5000 Health & Wellbeing UCITS ETF (C5KH) aims to ensure the world’s population has access to the health-related goods and services needed to live a healthful life. Access to healthcare services across and within countries varies significantly. Life expectancy globally is far from equal — there is a 30-year gap between Japan (85 years) and Lesotho (55 years). At least half of the world’s population does not have access to essential health services without being forced into financial poverty (WHO). The investee companies within C5KH aim to improve health impacts for people worldwide. C5KH aims to deliver investment results corresponding to the Bita CIRCA5000 Health & Wellbeing Impact Index.

As at 09/05/2024

Sub-theme Breakdown

Check out the specific areas of growth and innovation that this fund targets.

  1. Health 64.7%
  2. Housing 23.0%
  3. Sanitation 6.9%
  4. Care 1.4%

Positive Impact

We use external specialists to provide investment-grade data on the social and environmental outcomes of the companies within our funds.

  • 107M Patients Treated
  • 307K Lives Extended
  • 120k Cumulative affordable houses built or restored

CIRCA5000's strategy is to invest in companies that manufacture products, or offer the services that generate a positive environmental or social impact. For example, the homeowner who buys solar panels for their home is ultimately responsible for the positive impact generated and the company that manufactured them is the facilitator. Therefore, by investing in these companies, CIRCA5000 supports users to generate a positive impact, but we are of course, not responsible for it on our own.

This impact is therefore 'associated' rather than direct. We source our data from Net Purpose to ensure we have the most robust and complete data possible.

Data is annual and based on the latest company reports, with some additional products and services estimates provided by Net Purpose.

As at 08/05/2024

Index Performance

Past performance is not a reliable indicator of future performance. The figures in the chart above refer to simulated past performance from the Bita CIRCA5000 Health & Wellbeing Impact Index (BCHWII) established by BITA (www.bitadata.com). It is calculated using backtested performance data from the underlying holdings of the CIRCA5000 Health & Wellbeing UCITS ETF (C5KH) and the data is backtested from 07/03/2014. The performance is backtested index data which has been sourced from the index provider BITA and is based on what they perceive to be reasonable assumptions and objective data. The index currency is based in USD and gross of fees. Factors such as fund fees, trading fees and currency exchange rates may affect your return. The annual TER for C5KH is 0.49%. The index was changed on 07/05/2024 due to a change in impact data provider.

As at 09/05/2024

Fund Holdings

Download spreadsheet
Name
ISIN
HDFC Bank Ltd
US40415F1012
6.8%
Stryker
US8636671013
5.5%
Elevance Health Inc
US0367521038
4.0%
Agilent Technologies
US00846U1016
3.6%
Biogen
US09062X1037
3.5%
Molina Healthcare, Inc.
US60855R1005
3.1%
Danaher
US2358511028
3.0%
Sonova Holding AG
CH0012549785
2.7%
Astellas Pharma Inc.
JP3942400007
2.5%
Vonovia SE
DE000A1ML7J1
2.3%
Swedish Orphan Biovitrum
SE0000872095
2.3%
Fresenius SE & Co KGaA
DE0005785604
2.0%
Baxter
US0718131099
2.0%
United Therapeutics Corp
US91307C1027
1.9%
Genmab
DK0010272202
1.9%
Hologic Inc
US4364401012
1.8%
Xior Student Housing
BE0974288202
1.8%
Ultragenyx Pharma
US90400D1081
1.8%
Eurofins Scientific
FR0014000MR3
1.8%
Pentair
IE00BLS09M33
1.8%
American Water Works
US0304201033
1.8%
Getinge AB
SE0000202624
1.6%
Convatec
GB00BD3VFW73
1.6%
Recordati
IT0003828271
1.6%
Sun Communities Inc.
US8666741041
1.6%
Halma
GB0004052071
1.6%
Bouygues S.A.
FR0000120503
1.5%
LEG Immobilien
DE000LEG1110
1.5%
Rexnord Corp
US98983L1089
1.5%
HealthEquity, Inc.
US42226A1079
1.5%
Biomerieux
FR0013280286
1.4%
Symrise
DE000SYM9999
1.4%
Nexity S.A.
FR0010112524
1.4%
Hikma Pharmaceuticals
GB00B0LCW083
1.4%
Dr. Reddy's Laboratories Ltd
US2561352038
1.4%
Cavco Industries Inc
US1495681074
1.4%
Exact Sciences Corp
US30063P1057
1.3%
Elekta AB (publ)
SE0000163628
1.3%
Novonesis
DK0060336014
1.3%
Cochlear Ltd
AU000000COH5
1.3%
Ventas Inc.
US92276F1003
1.2%
Skyline Champion Corp
US8308301055
1.2%
Medibank Private Ltd
AU000000MPL3
1.2%
DSM-Firmenich
CH1216478797
1.2%
Persimmon Plc
GB0006825383
1.2%
Idorsia Ltd
CH0363463438
1.2%
Umh Properties Inc.
US9030021037
1.2%
Healthpeak Properties Inc.
US42250P1030
1.2%
Unite Group
GB0006928617
1.0%
Intra-Cellular Therapies Inc
US46116X1019
0.9%
Takuma Co Ltd
JP3462600002
0.9%
Sabesp
US20441A1025
0.5%
Grifols
ES0171996087
0.3%
Pennon Group
GB00BNNTLN49
0.3%
WELL Health Technologies Corp.
CA94947L1022
0.2%
Industrie De Nora S.p.A.
IT0005186371
0.1%
Amalgamated Bank
US0226711010
0.1%
Benesse Holdings
JP3835620000
0.1%
Beijing Enterprises Water Group
BMG0957L1090
0.1%
Omega Healthcare Investors Inc.
US6819361006
0.1%
JD Health International Inc.
KYG5074A1004
0.1%
Sabra Health Care Reit Inc.
US78573L1061
0.1%
Oxford Nanopore Technologies PLC
GB00BP6S8Z30
0.1%
Bavarian Nordic A/S
DK0015998017
0.1%
BioArctic AB
SE0010323311
0.0%
RWC
AU000000RWC7
0.0%
Balchem
US0576652004
0.0%
Hawkins, Inc.
US4202611095
0.0%
American Well Corp
US03044L1052
0.0%
United Natural Foods Inc.
US9111631035
0.0%
The North West Company
CA6632782083
0.0%
ACADIA Pharmaceuticals Inc
US0042251084
0.0%

As at 09/05/2024

Exposure Breakdown

Geography
USA
45.3%
29 Holdings
India
8.2%
2 Holdings
Germany
7.3%
4 Holdings
UK
7.0%
7 Holdings
France
6.1%
4 Holdings
Sweden
5.2%
4 Holdings
Switzerland
5.1%
3 Holdings
Japan
3.6%
3 Holdings

As at 08/05/2024

Fund Details

Fund AUM
USD 5,079,000
NAV per share
USD 5.08
Number of holdings
75
Ticker (USD)
C5KH
Ticker (GBP)
CKHG
ISIN
IE0001EY64U4
Base Currency
USD
Income Treatment
Accumulating
Inception Date
05/06/2023
Primary Exchange
London Stock Exchange
Total Expense Ratio (TER)
0.49%
Domicile
Ireland
Replication Method
Physical - Full Replication
Index Ticker
BCHWII
Index Provider
BITA GmbH
Issuer
CIRCA5000 ICAV
Promoter
CIRCA5000 UK Ltd
Investment Manager
Vident Advisory, LLC
Custodian
J.P. Morgan SE, Dublin Branch
SFDR Classification
Article 9
UCITS Compliant
Yes
UK Reporting Status
Yes
ISA Eligible
Yes
SIPP Eligible
Yes

Risks

Equity Risk

The fund may invest in equity securities which are subject to greater fluctuations than other assets. Factors which may affect the fluctuation including economic conditions, industry or company news. High volumes of trading may also see increased transaction costs.

Thematic Risk

The Fund may be subject to the risks associated with, but not limited to, investing in companies with a material exposure to the climate transition. These risks include the obsolescence of intellectual property as technology evolves and changes in regulation or government subsidies that may affect the revenue or profitability of a company.

Operational Risk

The Fund and its assets may experience material losses as a result of technology/system failures, human error, policy breaches, and/or incorrect valuation of units.

Market Risk

The risk that the market will go down in value, with the possibility that such changes will be sharp and unpredictable.

Currency Risk

Some of the Fund’s investments may be denominated in currencies other than the Fund’s base currency (USD) therefore investors may be affected by adverse movements of the denominated currency and the base currency.

Sustainability Risk

The Manager, acting in respect of the Fund, through the Investment Manager as its delegate, integrates sustainability risks into the investment decisions made in respect of the Fund. Given the investment strategy of the Fund and its risk profile, the likely impact of sustainability risks on the Fund’s returns is expected to be low.

Derivative Risk

The Fund may invest in Financial Derivative Instruments (FDIs) to hedge against risk, to increase return and/or for efficient portfolio management. There is no guarantee that the Fund’s use of derivatives for any purpose will be successful. Derivatives are subject to counterparty risk (including potential loss of instruments) and are highly sensitive to underlying price movements, interest rates and market volatility and therefore come with a greater risk.

Documents

Explore our other funds